CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for YD Bio Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

YD Bio Ltd
2F
No.3, Xingnan Street, Nangang District
Phone: +886 23820330p:+886 23820330 TAIPEI, 115  Taiwan Ticker: YDESYDES
Business Summary
YD Bio Ltd is a Taiwan-based company principally engaged in pioneering transformative solutions from early cancer detection to next-generation cell therapies to improve and extend patient lives. The Company’s core areas include non-invasive cancer detection tools for early diagnosis and monitoring, ophthalmologic products targeting dry eye conditions, and exosome-based therapeutics aimed at treating complex diseases. By integrating cutting-edge science with accessible solutions, YD Bio strives to improve patient outcomes and quality of life.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024YesYes---

Industries
SIC Code Description
6726 Unit investment trusts, face-amount certificate offices
6770 Blank checks
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Chief Financial Officer J. DouglasRamsey 64 6/1/2020 6/1/2020
President, Director Russell D.Griffin 61 6/1/2020 6/1/2020
Chief Operating Officer Charles C.Ross 68 6/1/2020 6/1/2020
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Breeze Acquisition Sub LLC 12920 SE 38th Street Bellevue WA United States

Business Names
Business Name
Breeze Acquisition Sub LLC
BRZH
YDES

General Information
Outstanding Shares: 70,319,824 (As of 8/28/2025)
Shareholders: 10
Stock Exchange: NASD
Federal Tax Id: 851849315


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 9, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!